New inhaled drug to replace traditional insulin
Hindustan Times (Lucknow) 14 November 2020
New inhaled drug to replace traditional insulin
Technosphere inhaled insulin delivery appears safe
Published on consultant360.com on 16 September 2020
Technosphere inhaled insulin delivery appears safe
(Summary: pooled data indicate that diabetes treatment with insulin powder via the breath-powered Technosphere (Mannkind) inhalation device is safe. But long-term information is lacking.
As Dr. Anastassios G. Pittas told Reuters Health by email, “This newest type of inhaled insulin is an improved version of the prior type in terms of convenience to the patient and ease of use.”
However, he added, “Given lack of long-term information on safety, inhaled insulin should be reserved for patients who need insulin treatment but who are unable or unwilling to use injectable insulin.”
In a September 2 online paper in The Lancet Diabetes & Endocrinology, Dr. Pittas, of Tufts Medical Center, Boston, and colleagues noted that they came to this conclusion after examining outcomes in trials comparing mealtime Technosphere inhaled insulin with placebo, subcutaneous insulin, or oral antidiabetic drugs.)
Inhaled insulin may eventually mean no more shots for some diabetics
Published on 16 June 2021 on nationalpost.com
Inhaled insulin may eventually mean no more shots for some diabetics
Weary of the needle jab, diabetics yearn for new form of insulin
Published on 15 June 2021 on washingtonpost.com
Weary of the needle jab, diabetics yearn for new form of insulin
MannKind’s inhaled insulin drug proves hard for diabetics to get
Published on 3 June 2021 on latimes.com
MannKind’s inhaled insulin drug proves hard for diabetics to get